Corcept Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	716.08	675.04	482.38	401.86	365.98	353.87	Upgrade
Revenue Growth (YoY)	25.71%	39.94%	20.04%	9.80%	3.42%	15.46%	Upgrade
Cost of Revenue	12.16	10.88	6.48	5.39	5.28	5.58	Upgrade
Gross Profit	703.92	664.16	475.89	396.47	360.7	348.29	Upgrade
Selling, General & Admin	351.63	280.32	184.26	152.85	122.36	105.33	Upgrade
Research & Development	250.84	246.89	184.35	130.99	113.86	114.76	Upgrade
Operating Expenses	602.47	527.21	368.61	283.84	236.22	220.09	Upgrade
Operating Income	101.45	136.95	107.28	112.63	124.48	128.2	Upgrade
Interest & Investment Income	24.26	24.54	17.28	3.56	0.53	3.4	Upgrade
Legal Settlements	-	-	-	-14	-	-	Upgrade
Pretax Income	126.21	161.49	124.56	116.19	125.01	131.6	Upgrade
Income Tax Expense	-7.44	20.28	18.42	14.77	12.49	25.59	Upgrade
Net Income	133.66	141.21	106.14	101.42	112.51	106.01	Upgrade
Preferred Dividends & Other Adjustments	1.64	1.48	0.64	0.13	-	-	Upgrade
Net Income to Common	132.01	139.73	105.5	101.29	112.51	106.01	Upgrade
Net Income Growth	6.09%	33.04%	4.66%	-9.86%	6.13%	12.56%	Upgrade
Shares Outstanding (Basic)	104	103	104	107	116	115	Upgrade
Shares Outstanding (Diluted)	118	113	112	116	126	124	Upgrade
Shares Change (YoY)	6.81%	1.55%	-3.64%	-7.94%	1.42%	1.33%	Upgrade
EPS (Basic)	1.27	1.35	1.02	0.95	0.97	0.92	Upgrade
EPS (Diluted)	1.11	1.23	0.94	0.87	0.89	0.85	Upgrade
EPS Growth	-1.47%	30.85%	8.05%	-2.25%	4.71%	10.39%	Upgrade
Free Cash Flow	180.27	195.9	126.9	119.91	167.42	150.73	Upgrade
Free Cash Flow Per Share	1.52	1.73	1.14	1.03	1.33	1.21	Upgrade
Gross Margin	98.30%	98.39%	98.66%	98.66%	98.56%	98.42%	Upgrade
Operating Margin	14.17%	20.29%	22.24%	28.03%	34.01%	36.23%	Upgrade
Profit Margin	18.44%	20.70%	21.87%	25.20%	30.74%	29.96%	Upgrade
Free Cash Flow Margin	25.17%	29.02%	26.31%	29.84%	45.75%	42.59%	Upgrade
EBITDA	102.62	137.75	108.32	113.89	125.96	128.73	Upgrade
EBITDA Margin	14.33%	20.41%	22.46%	28.34%	34.42%	36.38%	Upgrade
D&A For EBITDA	1.17	0.8	1.04	1.26	1.48	0.53	Upgrade
EBIT	101.45	136.95	107.28	112.63	124.48	128.2	Upgrade
EBIT Margin	14.17%	20.29%	22.24%	28.03%	34.01%	36.23%	Upgrade
Effective Tax Rate	-	12.56%	14.79%	12.71%	9.99%	19.45%	Upgrade

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q